Seeking Alpha

cnylax44

cnylax44
Send Message
View as an RSS Feed
View cnylax44's Comments BY TICKER:
Latest  |  Highest rated
  • Betting Splunk Goes Splat [View article]
    Doing a great job on SPLK----wonder who gave you that one ????
    Jan 28 09:16 AM | Likes Like |Link to Comment
  • Today's Market News To Trade On: 5 Stocks Moving On News [View article]
    CRUS---buy high, sell low ??? that doesn't seem to be a very profitable strategy to me.
    Jan 15 03:09 PM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    Another good call ! If you throw out 10 per day you gotta be right on some. But when you get paid to promote by the article BUYER BEWARE !
    Jan 15 03:00 PM | Likes Like |Link to Comment
  • 'Top Of The Class' Small Pharma Investments For 2013 [View article]
    Check your market cap on ACRX---you're only off by 50-60% !! No $100 payment to you for your reporting --- too sloppy.
    Jan 14 12:37 PM | Likes Like |Link to Comment
  • Upcoming FDA Approval Decision Dates For Q1 2013 [View article]
    Nothing new here.
    Jan 14 11:14 AM | Likes Like |Link to Comment
  • This Cheap BioPharma Has Further Upside Ahead [View article]
    Wow !!! Two articles today....that's an easy $200 for reporting ! Hilarious ! Waiting to see what's next to come----can't wait !
    Jan 7 03:00 PM | Likes Like |Link to Comment
  • 2 Biotech Companies Making Considerable Strides When It Comes To Pain Management [View article]
    Surprised no summary from Yahoo on the companies----you always do this to collect the $100 for an "article". Outstanding----keep up the great work ! We can only wait for your next great summary !
    Jan 4 10:52 AM | Likes Like |Link to Comment
  • Positives Mounting For Priceline [View article]
    Give that man his $100 for "covering" PCLN ! Outstanding, leading edge !! Wow---reiterated Buy at TheStreet !!!
    Jan 4 10:46 AM | 1 Like Like |Link to Comment
  • One Biotech Making Significant Strides When It Comes To Lymph Node Discovery [View article]
    Pay that man his $100 for his article !!!
    Jan 4 10:28 AM | Likes Like |Link to Comment
  • AcelRx Pharma: Pain Drug Developer With A Pair Of Q1 2013 Phase III Catalysts [View article]
    Good summary.
    Dec 22 10:17 AM | 1 Like Like |Link to Comment
  • Alexion Pharmaceuticals: On The Road From Orphan Drugs To Blockbuster Profits [View article]
    How would you guess ? If you are part of these ultra-ophan sectors you either get the drug or die.
    Dec 10 08:47 AM | Likes Like |Link to Comment
  • Alexion Pharmaceuticals (ALXN -3.3%) dips after Citigroup intitiates coverage with a tepid Neutral rating, saying its current risk/reward profile isn't attractive. The firm notes that ALXN is presently trading at a very high P/E multiple that reflects optimistic expectations for upward EPS revisions. If history is a guide, the company will need to post significant upside surprises to offset the natural multiple contraction that is likely ahead. [View news story]
    WOW----leading edge research ! I wonder if this "analyst" will be one of the 11,000 employees on the chopping block ?
    Dec 7 12:47 PM | Likes Like |Link to Comment
  • Alexion Pharmaceuticals: On The Road From Orphan Drugs To Blockbuster Profits [View article]
    When you compare ALXN with other biotechnology companies it stands out as unique with no peers in the world. Factor in the outstanding management which has been led by a great CEO who founded the company over 20 years ago and you have a great recipe for successful investing.
    Dec 3 12:25 PM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    No reason to think that the author remotely understands the technology or why it remotely stands a chance to be a technological game changer. When you're quickly off to comment on the retail industry before doubling back to update the world on the offshore energy industry, with a pit-stop in micro biotech -- then it becomes quite apparent that "rifle-shooting" from biotech to energy back to retail off to disrutive new technology renders the "author"....... ajack of all trades ? master of none ???
    Nov 29 10:26 PM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    When you churn out as many articles as you can it sure is easy to miss many relevant facts. When you get paid by piece it's virtually impossible to do any significant due diligence or develop any notable experience in so many fields. When you never know who is running a company nor met any of them and strictly relying on second-hand observations from others of course you're not going to have a detailed picture of what a company really does. It's just another opinion and shouldn't be valued any more than that.
    Nov 29 08:42 AM | Likes Like |Link to Comment
COMMENTS STATS
91 Comments
27 Likes